TCL Archive Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs October 15, 2010
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer June 5, 2009
TCL Archive In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees August 19, 1994
TCL Archive Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors. June 10, 2005
